Skip to main content

Table 3 Endpoints and paramters for the NTCP modelling [29, 30]]

From: Image guidance and positioning accuracy in clinical practice: influence of positioning errors and imaging dose on the real dose distribution for head and neck cancer treatment

Organ

Endpoint

m

n

Dose50 [Gy]

Parotid glands

Xerostomia

0.18

0.7

64.0

Spinal chord

Myelitis/Necrosis

0.175

0.05

66.5

Larynx

Edema

0.16

0.45

64.3